Rchr
J-GLOBAL ID：202001000069221447   Update date: Oct. 22, 2024

YAMAMOTO HIDETAKA

ヤマモト ヒデタカ | YAMAMOTO HIDETAKA
Affiliation and department：
Okayama University, Graduate School of Medicine, Dentistry & Pharmaceutical Science Department of Pathology

About Okayama University, Graduate School of Medicine, Dentistry & Pharmaceutical Science Department of Pathology


Job title： Professor
Research field  (1)： Human pathology
Research keywords  (6)： pathology ,  bone and soft tissue tumor ,  head and neck tumor ,  HPV-related tumors ,  gastrointestinal tumor ,  duodenal neoplasm of gastric phenotype
Research theme for competitive and other funds  (14)：
  • 2024 - 2028 治療抵抗性肉腫における免疫微小環境の空間的解明と新規治療法への展開
  • 2022 - 2026 IgG4関連疾患の異所性胚中心オルガノイドから病因解明と新規モデル動物の樹立
  • 2022 - 2025 Genomic and epigenomic histone alterations and role for osteogenic differentiation in bone tumors
  • 2021 - 2024 Molecular pathological analysis of salivary gland carcinomas promoting personalized medicine: A large-scale multicenter study
  • 2019 - 2023 Multi-omics analysis of the mechanisms of tumorigenesis and acquired treatment resistance in rare cancer, sarcoma
Show all
Papers (307)：
  • Ryosuke Kuga, Hidetaka Yamamoto, Fumiya Narutomi, Misa Suzuki, Rina Jiromaru, Takahiro Hongo, Kazuhisa Hachisuga, Nobuko Yasutake, Kiyoko Kato, Takashi Nakagawa, et al. The combination of p16 and Rb expression pattern is helpful to predict high-risk HPV infection and the primary site in lymph node metastases of squamous cell carcinoma. Pathology, research and practice. 2024. 263. 155642-155642
  • Ryosuke Kuga, Kazuki Hashimoto, Hidetaka Yamamoto, Midori Taniguchi, Tomomi Manako, Masanobu Sato, Ryunosuke Kogo, Mioko Matsuo, Yoshinao Oda, Takashi Nakagawa. Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy. Anticancer research. 2024. 44. 10. 4593-4603
  • Yuichi Shibui, Kenichi Kohashi, Yuko Hino, Akihiko Tamaki, Izumi Kinoshita, Hidetaka Yamamoto, Yasuharu Nakashima, Tatsuro Tajiri, Yoshinao Oda. Expression of Forkhead Box M1 and Anticancer Effects of FOXM1 Inhibition in Epithelioid Sarcoma. Laboratory investigation; a journal of technical methods and pathology. 2024. 104. 8. 102093-102093
  • Masaki Naka, Hidetaka Yamamoto, Kenichi Kohashi, Takeshi Iwasaki, Taro Mori, Miwako Nogami, Fumihiko Ookubo, Kayoko Higuchi, Toru Motoi, Yoshinao Oda. Reappraisal of bone and soft tissue cytopathology classification using the modified Milan system. Cancer cytopathology. 2024
  • Seiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, Hidetaka Yamamoto, Shinji Sakurai, Hirotoshi Kikuchi, Tatsuo Kanda, Yukinori Kurokawa, Haruhiko Cho, Toshirou Nishida, et al. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024. 29. 6. 647-680
ｍore...
MISC (615)：
  • 山元 英崇. 【頭頸部腫瘍II-上気道・口腔・顎顔面骨腫瘍-】上気道腫瘍のWHO分類改訂のポイント. 病理と臨床. 2024. 42. 7. 0642-0649
  • 野上 美和子, 山元 英崇. 【頭頸部腫瘍I-唾液腺腫瘍-】唾液腺腫瘍細胞診 ミラノシステムの活用. 病理と臨床. 2024. 42. 6. 0549-0555
  • 綾田 善行, 中田 英二, 尾崎 敏文, 山元 英崇. 非典型的な好酸性細胞とDDIT3遺伝子再構成を示す粘液型脂肪肉腫の1例. 日本整形外科学会雑誌. 2024. 98. 6. S1551-S1551
  • 尾辻 亮介, 秦 暢宏, 山元 英崇, 藤岡 寛, 三月田 祐平, 波多江 龍亮, 空閑 太亮, 溝口 昌弘, 吉本 幸司. WHO新分類(WHO2021)の課題とその克服2:脳腫瘍病理形態診断と分子診断の融合の可能性 Astrocytoma,IDH-mutantにおけるCDKN2A/B hemizygous deletionの意義とp16/MTAP免疫染色の有用性. Brain Tumor Pathology. 2024. 41. Suppl. 087-087
  • 犬塚 杏子, 次郎丸 梨那, 久我 亮介, 本郷 貴大, 古後 龍之介, 橋本 和樹, 松尾 美央子, 山元 英崇, 中川 尚志. 家族性大腸腺腫症に合併した甲状腺乳頭癌の2例. 耳鼻と臨床. 2024. 70. 3. 150-155
ｍore...
Education (1)：
  • 1993 - 1999 九州大学医学部医学科
Professional career (1)：
  • 医学博士 (九州大学)
Work history (1)：
  • 2022/12 - 現在 岡山大学 大学院医歯薬学総合研究科 病理学(腫瘍病理) 教授
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM